Effect of bone marrow mesenchymal stem cell transplantation on acute hepatic failure in rats

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1150-1158

  Yuan, Shufang ^a   Jiang, Tao ^b   Zheng, Rongjiong ^a   Sun, Lihua ^a   Cao, Guiqiu ^a   Zhang, Yuexin ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b Xinjiang Key Laboratory of Cardiovascular Disease Research   (China)

Author keywords

Acute hepatic failure; Bone mesenchymal stem cells; Cluster of differentiation 163; Interleukin 10; Rat model

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CLUSTER OF DIFFERENTIATION 163; INTERLEUKIN 10; PROTEIN; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; LIVER TRANSPLANTATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NICK END LABELING; NONHUMAN; RAT; WESTERN BLOTTING;

EID: 84906505860     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1848     Document Type: Article

References (33)

1. Lee WM, Squires RH Jr, Nyberg SL, Doo E and Hoofnagle JH: Acute liver failure: Summary of a workshop. Hepatology 47: 1401-1415, 2008.
2. Kung JW and Forbes SJ: Stem cells and liver repair. Curr Opin Biotechnol 20: 568-574, 2009.
3. Oertel M and Shafritz DA: Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 1782: 61-74, 2008.
4. Locke JE, Shamblott MJ and Cameron AM: Stem cells and the liver: clinical applications in transplantation. Adv Surg 43: 35-51, 2009.
5. Salama H, Zekri AR, Zern M, et al: Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant 19: 1475-1486, 2010.
6. Mark AL, Sun Z, Warren DS, et al: Stem cell mobilization is life saving in an animal model of acute liver failure. Ann Surg 252: 591-596, 2010.
7. Antoniades CG, Berry PA, Wendon JA and Vergani D: The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49: 845-861, 2008.
8. Stuart WD, Kulkarni RM, Gray JK, Vasiliauskas J, Leonis MA and Waltz SE: Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology 53: 1618-1628, 2011.
9. Taylor RC, Cullen SP and Martin SJ: Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241, 2008.
10. Malhi H, Guicciardi ME and Gores GJ: Hepatocyte death: a clear and present danger. Physiol Rev 90: 1165-1194, 2010.
11. Sulahian TH, Hintz KA, Wardwell K and Guyre PM: Development of an ELISA to measure soluble CD163 in biological fluids. J Immunol Methods 252: 25-31, 2001.
12. Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T and Onji M: Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 40: 52-56, 2005.
13. Sulahian TH, Högger P, Wahner AE, et al: Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12: 1312-1321, 2000.
14. Pae HO and Chung HT: Heme oxygenase-l: its therapeutic roles in inflammatory diseases. Immune Netw 9: 12-19, 2009.
15. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J and Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro-and antiinflammatory stimuli. J Leukoc Biol 67: 97-103, 2000.
16. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW and Yarmush ML: Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2: e941, 2007.
17. Kuo TK, Hung SP, Chuang CH, et al: Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134: 2111-2121, 2008.
18. Ismail A, Fouad O, Abdelnasser A, Chowdhury A and Selim A: Stem cell therapy improves the outcome of liver resection in cirrhotics. J Gastrointest Cancer 41: 17-23, 2010.
19. Stutchfield BM, Forbes SJ and Wigmore SJ: Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl 16: 827-836, 2010.
20. Cho KA, Ju SY, Cho SJ, et al: Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int 33: 772-777, 2009.
21. Enns GM and Millan MT: Cell-based therapies for metabolic liver disease. Mol Genet Metab 95: 3-10, 2008.
22. Miyazaki M, Hardjo M, Masaka T, et al: Isolation of a bone marrow-derived stem cell line with high proliferation potential and its application for preventing acute fatal liver failure. Stem Cells 25: 2855-2863, 2007.
23. Sensebé L and Bourin P: Mesenchymal stem cells for therapeutic purposes. Transplantation 87 (9 Suppl): S49-S53, 2009.
24. Miura M, Miura Y, Padilla-Nash HM, et al: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24: 1095-1103, 2006.
25. Liu F, Liu ZD, Wu N, Cong X, Fei R, Chen HS and Wei L: Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl 15: 1092-1100, 2009.
26. Muraca M: Evolving concepts in cell therapy of liver disease and current clinical perspectives. Dig Liver Dis 43: 180-187, 2011.
27. Rust C and Gores GJ: Apoptosis and liver disease. Am J Med 108: 567-574, 2000.
28. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K and Phinney DG: Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007, 2007.
29. Møller HJ, Frikke-Schmidt R, Moestrup SK, Nordestgaard BG and Tybjærg-Hansen A: Serum soluble CD163 predicts risk of type 2 diabetes in the general population. Clin Chem 57: 291-297, 2011.
30. Louis H, Le Moine O, Peny MO, et al: Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 112: 935-942, 1997.
31. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO and Landis RC: Hemoglobin scavenger receptor CDl63 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 94: 119-126, 2004.
32. Fabriek BO, van Bruggen R, Deng DM, et al: The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 113: 887-892, 2009.
33. Moreno JA, Muñoz-García B, Martín-Ventura JL, et al: The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. Atherosclerosis 207: 103-110, 2009.